טוען...
Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
OBJECTIVE: The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) trial demonstrated that combination therapy with metformin plus rosiglitazone provided superior durability of glycemic control compared with metformin alone, with significantly lower treatment failure rates (38.6 v...
שמור ב:
| פורמט: | Artigo |
|---|---|
| שפה: | Inglês |
| יצא לאור: |
American Diabetes Association
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3661836/ https://ncbi.nlm.nih.gov/pubmed/23704674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2393 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|